| 1 | controlling | 5,035 |
| 2 | adjusting | 4,155 |
| 3 | accounting | 1,587 |
| 4 | correcting | 518 |
| 5 | compensating | 60 |
| 6 | covarying | 15 |
| 7 | 'recommendations | 13 |
| 8 | moistening | 11 |
| 9 | pinch-3 | 4 |
| 10 | 'reward | 3 |
| 11 | 0.0724 | 2 |
| 12 | 0.3/100,000 | 2 |
| 13 | 0.78+/-0.01 | 2 |
| 14 | 26.4° | 2 |
| 15 | 375°c | 2 |
| 16 | 9.5mg/day | 2 |
| 17 | co-varying | 2 |
| 18 | haplotyping | 2 |
| 19 | heterotherapy | 2 |
| 20 | lycopene-supplementation | 2 |
| 21 | meta-analysing | 2 |
| 22 | mid-2015 | 2 |
| 23 | overcorrecting | 2 |
| 24 | pegifn-2a/ribavirin | 2 |
| 25 | post-cancerous | 2 |
| 26 | treadmill-test | 2 |
| 27 | 'donations | 1 |
| 28 | 'dysphagia | 1 |
| 29 | 1.0-500ng/ml | 1 |
| 30 | 15mins | 1 |
| 31 | 2-hours/week | 1 |
| 32 | 5.28° | 1 |
| 33 | 65s | 1 |
| 34 | 8h/d | 1 |
| 35 | a/3-10 | 1 |
| 36 | adjusment | 1 |
| 37 | anadjustment | 1 |
| 38 | analysis.data | 1 |
| 39 | baron-cohen | 1 |
| 40 | bench-set | 1 |
| 41 | blinded-ratings | 1 |
| 42 | bonuses/fy | 1 |
| 43 | cellprocessing | 1 |
| 44 | centroiding | 1 |
| 45 | consensus.data | 1 |
| 46 | cutting/in | 1 |
| 47 | doncaster | 1 |
| 48 | framelessly | 1 |
| 49 | free-falling | 1 |
| 50 | g-1-p | 1 |
| 51 | gavege | 1 |
| 52 | high-valence | 1 |
| 53 | hot-stretching | 1 |
| 54 | hypoxia/sd | 1 |
| 55 | h₂o₂-treated | 1 |
| 56 | igfbp- | 1 |
| 57 | igg-based | 1 |
| 58 | il‑1β‑culture | 1 |
| 59 | il‑1β‑treatment | 1 |
| 60 | industrialpurposes | 1 |
| 61 | injury/infection | 1 |
| 62 | intsss | 1 |
| 63 | jnds | 1 |
| 64 | koblenz | 1 |
| 65 | kruskal-wallis-h-test | 1 |
| 66 | ksom | 1 |
| 67 | l1-pcr | 1 |
| 68 | myoton-3 | 1 |
| 69 | non-emergently | 1 |
| 70 | nonfavor | 1 |
| 71 | npcr-rflp | 1 |
| 72 | olv/tlv | 1 |
| 73 | orohiopexy | 1 |
| 74 | otorhino | 1 |
| 75 | peg-ifnα2b/rbv+boceprevir | 1 |
| 76 | pericardioscopy | 1 |
| 77 | permp-c | 1 |
| 78 | ph2.5 | 1 |
| 79 | pragmatism.praying | 1 |
| 80 | pre-/postoperative | 1 |
| 81 | pre-acclimatization | 1 |
| 82 | pre-correcting | 1 |
| 83 | pro-supination | 1 |
| 84 | pubmed-medline/ovid | 1 |
| 85 | radio-iodinated | 1 |
| 86 | rejection-caused | 1 |
| 87 | renormalizing | 1 |
| 88 | repolishing | 1 |
| 89 | retracing | 1 |
| 90 | revision-surgery | 1 |
| 91 | rugosities | 1 |
| 92 | s100/receptor | 1 |
| 93 | solublizing | 1 |
| 94 | stitch-out | 1 |
| 95 | stopping/continuing | 1 |
| 96 | surgery.less | 1 |
| 97 | tentanizing | 1 |
| 98 | tetra-nonabdes | 1 |
| 99 | the12-week | 1 |
| 100 | tidsskrift | 1 |
| 101 | treadmill-delivered | 1 |
| 102 | truhlar | 1 |
| 103 | underbilling | 1 |
| 104 | water-aging | 1 |
| 105 | zhongguo | 1 |
| 106 | £4284 | 1 |
| 107 | ∼2°c | 1 |
| 108 | ≥13-fold | 1 |
| 1 | 'donations | 1 |
| 2 | 'dysphagia | 1 |
| 3 | 'recommendations | 13 |
| 4 | 'reward | 3 |
| 5 | 0.0724 | 2 |
| 6 | 0.3/100,000 | 2 |
| 7 | 0.78+/-0.01 | 2 |
| 8 | 1.0-500ng/ml | 1 |
| 9 | 15mins | 1 |
| 10 | 2-hours/week | 1 |
| 11 | 26.4° | 2 |
| 12 | 375°c | 2 |
| 13 | 5.28° | 1 |
| 14 | 65s | 1 |
| 15 | 8h/d | 1 |
| 16 | 9.5mg/day | 2 |
| 17 | a/3-10 | 1 |
| 18 | accounting | 1,587 |
| 19 | adjusment | 1 |
| 20 | adjusting | 4,155 |
| 21 | anadjustment | 1 |
| 22 | analysis.data | 1 |
| 23 | baron-cohen | 1 |
| 24 | bench-set | 1 |
| 25 | blinded-ratings | 1 |
| 26 | bonuses/fy | 1 |
| 27 | cellprocessing | 1 |
| 28 | centroiding | 1 |
| 29 | co-varying | 2 |
| 30 | compensating | 60 |
| 31 | consensus.data | 1 |
| 32 | controlling | 5,035 |
| 33 | correcting | 518 |
| 34 | covarying | 15 |
| 35 | cutting/in | 1 |
| 36 | doncaster | 1 |
| 37 | framelessly | 1 |
| 38 | free-falling | 1 |
| 39 | g-1-p | 1 |
| 40 | gavege | 1 |
| 41 | haplotyping | 2 |
| 42 | heterotherapy | 2 |
| 43 | high-valence | 1 |
| 44 | hot-stretching | 1 |
| 45 | hypoxia/sd | 1 |
| 46 | h₂o₂-treated | 1 |
| 47 | igfbp- | 1 |
| 48 | igg-based | 1 |
| 49 | il‑1β‑culture | 1 |
| 50 | il‑1β‑treatment | 1 |
| 51 | industrialpurposes | 1 |
| 52 | injury/infection | 1 |
| 53 | intsss | 1 |
| 54 | jnds | 1 |
| 55 | koblenz | 1 |
| 56 | kruskal-wallis-h-test | 1 |
| 57 | ksom | 1 |
| 58 | l1-pcr | 1 |
| 59 | lycopene-supplementation | 2 |
| 60 | meta-analysing | 2 |
| 61 | mid-2015 | 2 |
| 62 | moistening | 11 |
| 63 | myoton-3 | 1 |
| 64 | non-emergently | 1 |
| 65 | nonfavor | 1 |
| 66 | npcr-rflp | 1 |
| 67 | olv/tlv | 1 |
| 68 | orohiopexy | 1 |
| 69 | otorhino | 1 |
| 70 | overcorrecting | 2 |
| 71 | peg-ifnα2b/rbv+boceprevir | 1 |
| 72 | pegifn-2a/ribavirin | 2 |
| 73 | pericardioscopy | 1 |
| 74 | permp-c | 1 |
| 75 | ph2.5 | 1 |
| 76 | pinch-3 | 4 |
| 77 | post-cancerous | 2 |
| 78 | pragmatism.praying | 1 |
| 79 | pre-/postoperative | 1 |
| 80 | pre-acclimatization | 1 |
| 81 | pre-correcting | 1 |
| 82 | pro-supination | 1 |
| 83 | pubmed-medline/ovid | 1 |
| 84 | radio-iodinated | 1 |
| 85 | rejection-caused | 1 |
| 86 | renormalizing | 1 |
| 87 | repolishing | 1 |
| 88 | retracing | 1 |
| 89 | revision-surgery | 1 |
| 90 | rugosities | 1 |
| 91 | s100/receptor | 1 |
| 92 | solublizing | 1 |
| 93 | stitch-out | 1 |
| 94 | stopping/continuing | 1 |
| 95 | surgery.less | 1 |
| 96 | tentanizing | 1 |
| 97 | tetra-nonabdes | 1 |
| 98 | the12-week | 1 |
| 99 | tidsskrift | 1 |
| 100 | treadmill-delivered | 1 |
| 101 | treadmill-test | 2 |
| 102 | truhlar | 1 |
| 103 | underbilling | 1 |
| 104 | water-aging | 1 |
| 105 | zhongguo | 1 |
| 106 | £4284 | 1 |
| 107 | ∼2°c | 1 |
| 108 | ≥13-fold | 1 |
| 1 | igfbp- | 1 |
| 2 | 0.3/100,000 | 2 |
| 3 | a/3-10 | 1 |
| 4 | 0.78+/-0.01 | 2 |
| 5 | pinch-3 | 4 |
| 6 | myoton-3 | 1 |
| 7 | 0.0724 | 2 |
| 8 | £4284 | 1 |
| 9 | ph2.5 | 1 |
| 10 | mid-2015 | 2 |
| 11 | 'dysphagia | 1 |
| 12 | analysis.data | 1 |
| 13 | consensus.data | 1 |
| 14 | permp-c | 1 |
| 15 | ∼2°c | 1 |
| 16 | 375°c | 2 |
| 17 | 8h/d | 1 |
| 18 | treadmill-delivered | 1 |
| 19 | igg-based | 1 |
| 20 | rejection-caused | 1 |
| 21 | h₂o₂-treated | 1 |
| 22 | radio-iodinated | 1 |
| 23 | pubmed-medline/ovid | 1 |
| 24 | ≥13-fold | 1 |
| 25 | 'reward | 3 |
| 26 | hypoxia/sd | 1 |
| 27 | high-valence | 1 |
| 28 | gavege | 1 |
| 29 | il‑1β‑culture | 1 |
| 30 | pre-/postoperative | 1 |
| 31 | retracing | 1 |
| 32 | centroiding | 1 |
| 33 | water-aging | 1 |
| 34 | hot-stretching | 1 |
| 35 | repolishing | 1 |
| 36 | free-falling | 1 |
| 37 | underbilling | 1 |
| 38 | controlling | 5,035 |
| 39 | moistening | 11 |
| 40 | haplotyping | 2 |
| 41 | cellprocessing | 1 |
| 42 | meta-analysing | 2 |
| 43 | compensating | 60 |
| 44 | correcting | 518 |
| 45 | pre-correcting | 1 |
| 46 | overcorrecting | 2 |
| 47 | accounting | 1,587 |
| 48 | adjusting | 4,155 |
| 49 | stopping/continuing | 1 |
| 50 | pragmatism.praying | 1 |
| 51 | co-varying | 2 |
| 52 | covarying | 15 |
| 53 | renormalizing | 1 |
| 54 | solublizing | 1 |
| 55 | tentanizing | 1 |
| 56 | the12-week | 1 |
| 57 | 2-hours/week | 1 |
| 58 | 1.0-500ng/ml | 1 |
| 59 | ksom | 1 |
| 60 | baron-cohen | 1 |
| 61 | cutting/in | 1 |
| 62 | pegifn-2a/ribavirin | 2 |
| 63 | pro-supination | 1 |
| 64 | lycopene-supplementation | 2 |
| 65 | pre-acclimatization | 1 |
| 66 | injury/infection | 1 |
| 67 | otorhino | 1 |
| 68 | zhongguo | 1 |
| 69 | g-1-p | 1 |
| 70 | npcr-rflp | 1 |
| 71 | truhlar | 1 |
| 72 | l1-pcr | 1 |
| 73 | doncaster | 1 |
| 74 | peg-ifnα2b/rbv+boceprevir | 1 |
| 75 | s100/receptor | 1 |
| 76 | nonfavor | 1 |
| 77 | 65s | 1 |
| 78 | jnds | 1 |
| 79 | tetra-nonabdes | 1 |
| 80 | rugosities | 1 |
| 81 | industrialpurposes | 1 |
| 82 | blinded-ratings | 1 |
| 83 | 15mins | 1 |
| 84 | 'recommendations | 13 |
| 85 | 'donations | 1 |
| 86 | surgery.less | 1 |
| 87 | intsss | 1 |
| 88 | post-cancerous | 2 |
| 89 | bench-set | 1 |
| 90 | tidsskrift | 1 |
| 91 | adjusment | 1 |
| 92 | il‑1β‑treatment | 1 |
| 93 | anadjustment | 1 |
| 94 | kruskal-wallis-h-test | 1 |
| 95 | treadmill-test | 2 |
| 96 | stitch-out | 1 |
| 97 | olv/tlv | 1 |
| 98 | 9.5mg/day | 2 |
| 99 | bonuses/fy | 1 |
| 100 | framelessly | 1 |
| 101 | non-emergently | 1 |
| 102 | heterotherapy | 2 |
| 103 | pericardioscopy | 1 |
| 104 | revision-surgery | 1 |
| 105 | orohiopexy | 1 |
| 106 | koblenz | 1 |
| 107 | 26.4° | 2 |
| 108 | 5.28° | 1 |